Robeco Institutional Asset Management B.V. Grows Stock Holdings in HCA Healthcare, Inc. $HCA

Robeco Institutional Asset Management B.V. grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 21.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,692 shares of the company’s stock after buying an additional 3,625 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in HCA Healthcare were worth $9,660,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of HCA. Palisade Asset Management LLC purchased a new stake in HCA Healthcare during the third quarter worth approximately $26,000. Holos Integrated Wealth LLC purchased a new stake in HCA Healthcare during the fourth quarter worth approximately $29,000. Harbor Capital Advisors Inc. boosted its stake in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the period. JPL Wealth Management LLC purchased a new position in shares of HCA Healthcare in the third quarter valued at $33,000. Finally, Aventura Private Wealth LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $34,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on HCA shares. KeyCorp set a $503.00 target price on shares of HCA Healthcare in a research note on Wednesday, January 28th. Jefferies Financial Group upped their target price on shares of HCA Healthcare from $535.00 to $590.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Mizuho increased their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Truist Financial increased their price target on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, The Goldman Sachs Group increased their price target on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $537.36.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $489.00 on Thursday. The firm’s 50-day moving average is $511.89 and its 200-day moving average is $483.30. HCA Healthcare, Inc. has a 1 year low of $314.43 and a 1 year high of $556.52. The company has a market cap of $109.33 billion, a P/E ratio of 17.23, a PEG ratio of 1.53 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same period last year, the firm posted $6.22 EPS. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is 10.99%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This trade represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.